Pfizer, Serum File EUAs For COVID-19 Vaccines In India

Questions Remain Over Serum's Adverse Event

 
• By Vibha Ravi
  
As COVID-19 Vaccines Zip Ahead To Launch, Questions Linger • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip